Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).

Pharmacokinetics, Dynamics and Metabolism, New Chemical Entities, Groton, Connecticut (Z.M., R.S., M.T., A.D.V., E.C.) and Cambridge, Massachusetts (A.S.K.); Cardiovascular, Metabolic and Endocrine Diseases Research Unit (N.A.); Clinical Pharmacology, Cambridge, Massachusetts (G.N.); and Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut (V.M.).